|
Therapy Area
Chronic obstructive pulmonary disease. |
|
In phase
Preclinical optimization phase. |
Competitive Edge
Potent MMP-12 protease inhibitor with high selectivity has been identified. There is currently no satisfactory treatment against COPD. |
Project Data
Highly effective and selective inhibitor substances identified.
Significant efficacy demonstrated in a preclinical in vivo test model of COPD.
|
|
|
| |
|
